A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection

Morano Amado, Luis

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/2304

DOI: 10.1002/hep.26858

ISSN: 0270-9139

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2013

Journal title

Hepatology

Type of content

Publicación de congreso